Four major algorithms used for signal detection. حسب Xiaoling Zhong (181270)

Four major algorithms used for signal detection. حسب Ruibo Li (2063167)

الموضوعات:

Signal strength of adverse events that are unexpected findings of Relugolix (Orgovyx^®)-related adverse events at the preferred term (PT) level. حسب Ruibo Li (2063167)

الموضوعات:

Formulas and criteria for signal detection algorithms in pharmacovigilance. حسب Yinrui Fang (22169878)

الموضوعات: "…four disproportionality algorithms…"

Clinical characteristics of adverse events to Relugolix (Orgovyx^®). حسب Ruibo Li (2063167)

الموضوعات:

Time to onset of Relugolix (Orgovyx^®)-related adverse events. حسب Ruibo Li (2063167)

الموضوعات:

The number of adverse event reports at the SOC level. حسب Yinrui Fang (22169878)

الموضوعات: "…four disproportionality algorithms…"

Dataset for Fine-Tuning Code Generation Models: Kannada-English Algorithmic Statements and Python Code حسب Goutami Sooda (20714729)

Onset time of adverse events associated with sodium zirconium cyclosilicate. حسب Yinrui Fang (22169878)

الموضوعات: "…four disproportionality algorithms…"

Forest plot of effect estimates for adverse-event reports at the SOC level. حسب Yinrui Fang (22169878)

الموضوعات: "…four disproportionality algorithms…"

Comparison of disproportionality signals for shared adverse events between SZC and patiromer. حسب Yinrui Fang (22169878)

الموضوعات: "…four disproportionality algorithms…"

Four major algorithms used to assess potential associations between CDK4/6 inhibitors and AEs. حسب Siqi Zhang (1397044)

Summary of baseline characteristics, disproportionality analysis, onset-time distribution, and additional analyses for SZC adverse events in FAERS. حسب Yinrui Fang (22169878)

الموضوعات: "…four disproportionality algorithms…"

Time to onset of SZC-related AEs. حسب Yongfei Yu (3083934)

الموضوعات:

Data and code resources. حسب Sam Hall-McMaster (10343795)

Study area and conceptual diagram of algorithm implementation in one community health worker catchment. حسب Mauricianot Randriamihaja (9091488)

Flow diagram of the study. حسب Ruibo Li (2063167)

الموضوعات:

Signal strength of reports of Relugolix (Orgovyx^®) at the Preferred Term (PT) level. حسب Ruibo Li (2063167)

الموضوعات:

The signal strength of Relugolix (Orgovyx^®) at the System Organ Class (SOC) level. حسب Ruibo Li (2063167)

الموضوعات:

Time to onset of Lifitegrast-related AEs. حسب Chu Zhang (626017)

الموضوعات: